Glucagon Nasal Spray Administration Parameters
Administer a single 3 mg dose of nasal glucagon into one nostril for patients aged 4 years and older with severe hypoglycemia who cannot swallow. 1
Dosing
- Single fixed dose: 3 mg administered intranasally
- No weight-based or age-based adjustments needed for patients ≥4 years old 2
- One dose per device (single-use only)
Administration Technique
The nasal glucagon device is designed for rapid, simple administration:
- Insert the tip into one nostril and press the plunger fully
- Patient does NOT need to inhale or sniff - the powder is passively absorbed through the nasal mucosa 3
- No reconstitution required - the device is ready to use immediately 2
- Can be administered by untrained caregivers or bystanders 4
Expected Response Timeline
Most patients (>95%) will awaken or return to normal status within 15-30 minutes of administration 5:
- Mean time to treatment success: 10-20 minutes 6
- In severe hypoglycemic events, patients typically awaken within 15 minutes without requiring additional external medical help 5
- Treatment success is defined as blood glucose increase to ≥70 mg/dL or an increase of ≥20 mg/dL from nadir within 30 minutes 7
Critical Action Points
Call emergency medical services (EMS) if:
- Patient does not improve within 10 minutes of glucagon administration 8
- Patient has a seizure 8
- Patient remains unable to swallow after initial response 8
After the patient responds:
- Give oral carbohydrates once the patient is awake and able to swallow
- Monitor blood glucose levels closely
Common Pitfalls to Avoid
- Do NOT attempt oral glucose in unconscious patients - this creates aspiration risk 8
- Do NOT delay administration trying to reconstitute injectable glucagon - nasal glucagon is administered in <1 minute versus 1-5 minutes for intramuscular formulations 6
- Do NOT assume one dose is insufficient - studies show >98% success with single 3 mg dose 2
Expected Adverse Effects
The most common side effects are transient and manageable 6, 2:
- Nausea and vomiting (occurs in ~42% of nasal administrations)
- Nasal symptoms: watery eyes, runny nose (more common with nasal route than injectable)
- Headache
These effects are typically mild-to-moderate and resolve spontaneously.
Practical Advantages
The 2023 Endocrine Society guidelines emphasize that ease of administration is critical because family members and friends typically administer glucagon during emergencies, often at night in high-stress situations 4. Nasal glucagon addresses the historical problem of frequent failure to administer full therapeutic doses with reconstituted injectable glucagon, which previously led to unnecessary emergency department visits and hospitalizations 4.
Caregivers consistently find nasal glucagon easier and less intimidating than injectable formulations, particularly in pediatric populations 4. The single-step, needle-free administration removes barriers related to needle phobia and complex preparation procedures 2.